Topic
Biotech
2 posts
NVAX Stock Forecast: Is Novavax a Buy on Its High-Margin Pivot?
NVAX stock deep dive: Is Novavax a buy in 2026? Discover how Q1 earnings, Pfizer and Sanofi licensing deals, and the Matrix-M adjuvant pivot reshape NVAX's value.
May 23, 2026·9 min read
XBI Stock Forecast: Is This Biotech ETF a Buy in 2026?
Thinking of investing in XBI stock? Discover how this equal-weighted biotech ETF performs, its top holdings, key risks, and why it's a major player in 2026.
May 22, 2026·11 min read